Information on the Total Number of Voting Rights (denominator) following Exercise of a Call Option from Goldman Sachs


Liege, Belgium, 20 April 2022 – 07:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that Goldman Sachs International (“GSI”) has elected to exercise a call option for an amount of EUR 5,000,000 on 19 April, 2022, according to the terms of the equity funding agreement signed with GSI on February 4, 2022. This call option will result in the issuance of 489,686 shares of the Company.